Growth factors (Chur, Switzerland)

Keyphrases

Publications

2024

Huaizhong Zhang, Keng Chen, Yongqing Zhou, Zhuo Cao, Cunlai Xu, Lin Zhou, Gongzhi Wu, Congxiong Peng, Songqing Lai, Xuhui Wu
PLA2G2D fosters angiogenesis in non-small cell lung cancer through aerobic glycolysis. Growth factors (Chur, Switzerland) (2024)
Ashita Gadwal, Purvi Purohit, Manoj Khokhar, Jeewan Ram Vishnoi, Puneet Pareek, Ramkaran Choudhary, Poonam Elhence, Mithu Banerjee, Praveen Sharma
GALNT6, GALNT14, and Gal-3 in association with GDF-15 promotes drug resistance and stemness of breast cancer via β-catenin axis. Growth factors (Chur, Switzerland) (2024)
Ruonan Zhou, Yingying Xue, Ziwei Zhu, Pingyuan Xu, Lixuan Shen, Ziwei Wang, Yingying Xiang, Yue Cao, Xizhong Yu, Wenbin Shang
VEGF-B is involved in diabetic peripheral neuropathy in patients with type 2 diabetes. Growth factors (Chur, Switzerland) (2024)
Emma J Thompson, Samantha Escarbe, Denis Tvorogov, Gelareh Farshid, Philip A Gregory, Yeesim Khew-Goodall, Stephen Madden, Wendy V Ingman, Geoffrey J Lindeman, Elgene Lim, Angel F Lopez, Claudine S Bonder
Interleukin-3 production by basal-like breast cancer cells is associated with poor prognosis. Growth factors (Chur, Switzerland) (2024)
Yousif Hikmat, Alireza Safarzade, Hamid Alizadeh
Comparative effects of 8-week combined resistance exercise training and alternate-day calorie restriction on soluble epidermal growth factor receptor (sEGFR) and adipsin in obese men. Growth factors (Chur, Switzerland) (2024)

volume 42, number 2, 2024

Ashita Gadwal, Purvi Purohit, Manoj Khokhar, Jeewan Ram Vishnoi, Puneet Pareek, Ramkaran Choudhary, Poonam Elhence, Mithu Banerjee, Praveen Sharma
GALNT6, GALNT14, and Gal-3 in association with GDF-15 promotes drug resistance and stemness of breast cancer via β-catenin axis. Growth factors (Chur, Switzerland) 42 (2) (2024)
Huaizhong Zhang, Keng Chen, Yongqing Zhou, Zhuo Cao, Cunlai Xu, Lin Zhou, Gongzhi Wu, Congxiong Peng, Songqing Lai, Xuhui Wu
PLA2G2D fosters angiogenesis in non-small cell lung cancer through aerobic glycolysis. Growth factors (Chur, Switzerland) 42 (2) (2024)
Huaizhong Zhang, Keng Chen, Yongqing Zhou, Zhuo Cao, Cunlai Xu, Lin Zhou, Gongzhi Wu, Congxiong Peng, Songqing Lai, Xuhui Wu
PLA2G2D fosters angiogenesis in non-small cell lung cancer through aerobic glycolysis. Growth factors (Chur, Switzerland) 42 (2) (2024)
Emma J Thompson, Samantha Escarbe, Denis Tvorogov, Gelareh Farshid, Philip A Gregory, Yeesim Khew-Goodall, Stephen Madden, Wendy V Ingman, Geoffrey J Lindeman, Elgene Lim, Angel F Lopez, Claudine S Bonder
Interleukin-3 production by basal-like breast cancer cells is associated with poor prognosis. Growth factors (Chur, Switzerland) 42 (2) (2024)
Liang Li, XueFeng Sun, Mei Zhang, BangShuo Zhang, Yi Yang, Sheng Wang
FOXN2, identified as a novel biomarker in serum, modulates the transforming growth factor-beta signaling pathway through its interaction with partitioning defective 6 homolog alpha, contributing to the pathogenesis of gastric cancer. Growth factors (Chur, Switzerland) 42 (2) (2024)
Liang Li, XueFeng Sun, Mei Zhang, BangShuo Zhang, Yi Yang, Sheng Wang
FOXN2, identified as a novel biomarker in serum, modulates the transforming growth factor-beta signaling pathway through its interaction with partitioning defective 6 homolog alpha, contributing to the pathogenesis of gastric cancer. Growth factors (Chur, Switzerland) 42 (2) (2024)
Ashita Gadwal, Purvi Purohit, Manoj Khokhar, Jeewan Ram Vishnoi, Puneet Pareek, Ramkaran Choudhary, Poonam Elhence, Mithu Banerjee, Praveen Sharma
GALNT6, GALNT14, and Gal-3 in association with GDF-15 promotes drug resistance and stemness of breast cancer via β-catenin axis. Growth factors (Chur, Switzerland) 42 (2) (2024)
Emma J Thompson, Samantha Escarbe, Denis Tvorogov, Gelareh Farshid, Philip A Gregory, Yeesim Khew-Goodall, Stephen Madden, Wendy V Ingman, Geoffrey J Lindeman, Elgene Lim, Angel F Lopez, Claudine S Bonder
Interleukin-3 production by basal-like breast cancer cells is associated with poor prognosis. Growth factors (Chur, Switzerland) 42 (2) (2024)
Ashita Gadwal, Purvi Purohit, Manoj Khokhar, Jeewan Ram Vishnoi, Puneet Pareek, Ramkaran Choudhary, Poonam Elhence, Mithu Banerjee, Praveen Sharma
GALNT6, GALNT14, and Gal-3 in association with GDF-15 promotes drug resistance and stemness of breast cancer via β-catenin axis. Growth factors (Chur, Switzerland) 42 (2) (2024)
Liang Li, XueFeng Sun, Mei Zhang, BangShuo Zhang, Yi Yang, Sheng Wang
FOXN2, identified as a novel biomarker in serum, modulates the transforming growth factor-beta signaling pathway through its interaction with partitioning defective 6 homolog alpha, contributing to the pathogenesis of gastric cancer. Growth factors (Chur, Switzerland) 42 (2) (2024)
Emma J Thompson, Samantha Escarbe, Denis Tvorogov, Gelareh Farshid, Philip A Gregory, Yeesim Khew-Goodall, Stephen Madden, Wendy V Ingman, Geoffrey J Lindeman, Elgene Lim, Angel F Lopez, Claudine S Bonder
Interleukin-3 production by basal-like breast cancer cells is associated with poor prognosis. Growth factors (Chur, Switzerland) 42 (2) (2024)

2023

Ziwei Wang
Role of transforming growth factor-β in airway remodelling in bronchiolitis obliterans. Growth factors (Chur, Switzerland) (2023)
Robert George Ramsay, Vicki Whitehall, Michael P Flood
Technological advances define shifting pathway signaling from normal to primary and metastatic colorectal cancer. Growth factors (Chur, Switzerland) (2023)
YongChao Wang, Qin Su, HaiRong Tang, Qiang Tian, Xin Lin, MeiChun Fu, RenMing Zhang, ZhangFeng Luo, KeYun Zhang
Microfracture technique combined with mesenchymal stem cells inducer represses miR-708-5p to target special at-rich sequence-binding protein 2 to drive cartilage repair and regeneration in rabbit knee osteoarthritis. Growth factors (Chur, Switzerland) (2023)
Eva Székiová, Zuzana Michalová, Juraj Blaško, Rastislav Mucha, Lucia Slovinska, Martin Kello, Ivo Vanický
Characterisation of mesenchymal stem cells conditioned media obtained at different conditioning times: their effect on glial cells in in vitro scratch model. Growth factors (Chur, Switzerland) (2023)
Amin Ramezani, Mohammadrasul Zareinejad, Elham Mahmoudi Maymand, Elina Kaviani, Abbas Ghaderi
Production of a biosimilar version of aflibercept to improve VEGF blocker cytotoxicity on endothelial cells. Growth factors (Chur, Switzerland) (2023)
Andrija Jurina, Dino Kasumović, Valentina Delimar, Tajana Filipec Kanižaj, Mladen Japjec, Tomislav Dujmović, Marijana Vučić Lovrenčić, Mario Starešinić
Fibroblast growth factor 23 and its role in bone diseases. Growth factors (Chur, Switzerland) (2023)
Yuyu Wang, Jianjiang Huang, Fang Zhang, Keli Shen, Bin Qiu
Knock-down of IGFBP2 ameliorates lung fibrosis and inflammation in rats with severe pneumonia through STAT3 pathway. Growth factors (Chur, Switzerland) (2023)
Jinling Zhang, Ruiqing Li, Yang Yu, Weijia Sun, Chengshi Zhang, Haijun Wang
Network pharmacology-and molecular docking-based investigation of Danggui blood-supplementing decoction in ischaemic stroke. Growth factors (Chur, Switzerland) (2023)
Fanbo Meng, Liting Dai
Transcription factors TP63 facilitates malignant progression of thyroid cancer by upregulating KRT17 expression and inducing epithelial-mesenchymal transition. Growth factors (Chur, Switzerland) (2023)
Xingqiao Xie, Xumao Li, Xinsheng Lin, Xiangyu Chen, Chenshan Zhang, Guangbin Sun
Effects of hepatocyte growth factor-transfected mesenchymal stem cell transplantation in canine injured vocal folds. Growth factors (Chur, Switzerland) (2023)
Siqi Wu, Rodney Brian Luwor, Hong-Jian Zhu
Dynamics of transforming growth factor β signaling and therapeutic efficacy. Growth factors (Chur, Switzerland) (2023)
Mehrsa Nasiri, Javad Esmaeili, Amir Tebyani, Hojat Basati
A review about the role of additives in nerve tissue engineering: growth factors, vitamins, and drugs. Growth factors (Chur, Switzerland) (2023)
Hanqin Weng, Weijian Feng, Fengling Li, Dong Huang, Liangyi Lin, Zaiguo Wang
Transcription factor ETV1-induced lncRNA MAFG-AS1 promotes migration, invasion, and epithelial-mesenchymal transition of pancreatic cancer cells by recruiting IGF2BP2 to stabilize ETV1 expression. Growth factors (Chur, Switzerland) (2023)
Aysan Lektemür Alpan, Gizem Torumtay, Alper Kızıldağ, Necati Zavrak, Özlem Özmen, Şevki Arslan, Doğukan Mutlu
Evaluation of the effect of injectable platelet-rich fibrin (i-PRF) in wound healing and growth factor release in rats: a split-mouth study. Growth factors (Chur, Switzerland) (2023)
Simin Riahy
The effects of 12 weeks of high-intensity interval training and moderate-intensity continuous training on FGF21, irisin, and myostatin in men with type 2 diabetes mellitus. Growth factors (Chur, Switzerland) (2023)
Sareh Hosseini, Mohammad Sadegh Soltani-Zangbar, Majid Zamani, Yoda Yaghoubi, Reza Rikhtegar Ghiasi, Roza Motavalli, Ali Ghassabi, Rahim Iranzad, Amir Mehdizadeh, Seyed Kazem Shakouri, Alireza Pishgahi, Mehdi Yousefi
Comparative evaluation of autologous platelet-rich plasma and platelet lysate in patients with knee osteoarthritis. Growth factors (Chur, Switzerland) (2023)

volume 41, number 1, 2022

Yanfei Tang, Guangtao Xu, Bo Hu, Yuzhang Zhu
HIVEP3 as a potential prognostic factor promotes the development of acute myeloid leukemia. Growth factors (Chur, Switzerland) 41 (1) (2022)
Yanfei Tang, Guangtao Xu, Bo Hu, Yuzhang Zhu
HIVEP3 as a potential prognostic factor promotes the development of acute myeloid leukemia. Growth factors (Chur, Switzerland) 41 (1) (2022)
Yanfei Tang, Guangtao Xu, Bo Hu, Yuzhang Zhu
HIVEP3 as a potential prognostic factor promotes the development of acute myeloid leukemia. Growth factors (Chur, Switzerland) 41 (1) (2022)
Yanfei Tang, Guangtao Xu, Bo Hu, Yuzhang Zhu
HIVEP3 as a potential prognostic factor promotes the development of acute myeloid leukemia. Growth factors (Chur, Switzerland) 41 (1) (2022)

volume 40, number 3-4, 2022

Elham Bahador Zırh, Elif Taşar Kapaklı, Anil Barak Dolgun, Alp Usubütün, Naciye Dilara Zeybek
The expression of BMP, integrin, ZEB2 in ovarian high-grade serous carcinoma in relation with lymph node metastasis. Growth factors (Chur, Switzerland) 40 (3-4) (2022)
Oliver Cucanic, Rae H Farnsworth, Steven A Stacker
The cellular and molecular mediators of metastasis to the lung. Growth factors (Chur, Switzerland) 40 (3-4) (2022)
Yujie Li, Xinyue Liu, Xueli Liu, Yuanqiu Peng, Bin Zhu, Sheng Guo, Chenglong Wang, Dingxuan Wang, Sen Li
Transforming growth factor-β signalling pathway in tendon healing. Growth factors (Chur, Switzerland) 40 (3-4) (2022)
Anandini Swaminathan, Leonardo Cesanelli, Tomas Venckunas, Hans Degens
Impact of methionine restriction on muscle aerobic metabolism and hypertrophy in young and old mice on an obesogenic diet. Growth factors (Chur, Switzerland) 40 (3-4) (2022)
Aakansha Giri Goswami, Somprakas Basu, Farhanul Huda, Jayanti Pant, Amrita Ghosh Kar, Tuhina Banerjee, Vijay Kumar Shukla
An appraisal of vascular endothelial growth factor (VEGF): the dynamic molecule of wound healing and its current clinical applications. Growth factors (Chur, Switzerland) 40 (3-4) (2022)

volume 40, number 5-6, 2022

Ling Qiang Bai, Bin Zhe Wang, Qi Wei Liu, Wen Qiang Li, Hang Zhou, Xiao Yan Yang
Effects of penehyclidine hydrochloride on myocardial ischaemia-reperfusion injury in rats by inhibiting TLR4/MyD88/NF-κB pathway via miR-199a-3p. Growth factors (Chur, Switzerland) 40 (5-6) (2022)
BaoLin Wang, HuiHai Wang, Qin Zhao, Fei Lu, ZhenZhuang Yan, Fang Zhou, QingLun Su
Matrine induces hepatocellular carcinoma apoptosis and represses EMT and stemness through microRNA-299-3p/PGAM1 axis. Growth factors (Chur, Switzerland) 40 (5-6) (2022)
Lingli Guo, Baohua Wei, Feng Pan, Hasi Wulan, Mi Cai
Effects of dual-gene modification on biological characteristics of vascular endothelial cells and their significance as reserving cells for chronic wound repair. Growth factors (Chur, Switzerland) 40 (5-6) (2022)
Katarina Mirjačić Martinović, Ana Vuletić, Emina Mališić, Tatjana Srdić-Rajić, Nevena Tišma Miletić, Nada Babović, Vladimir Jurišić
Increased circulating TGF-β1 is associated with impairment in NK cell effector functions in metastatic melanoma patients. Growth factors (Chur, Switzerland) 40 (5-6) (2022)
Hussein Kadhem Al-Hakeim, Qasim Jasim Al-Kaabi, Michael Maes
High mobility group box 1 and Dickkopf-related protein 1 as biomarkers of glucose toxicity, atherogenicity, and lower β cell function in patients with type 2 diabetes mellitus. Growth factors (Chur, Switzerland) 40 (5-6) (2022)
Raha Markazi, Mohammad Sadegh Soltani-Zangbar, Majid Zamani, Shadi Eghbal-Fard, Roza Motavalli, Amin Kamrani, Sanam Dolati, Majid Ahmadi, Leili Aghebati Maleki, Amir Mehdizadeh, Fariba Eslamian, Alireza Pishgahi, Mehdi Yousefi
Platelet lysate and tendon healing: comparative analysis of autologous frozen-thawed PRP and ketorolac tromethamine in the treatment of patients with rotator cuff tendinopathy. Growth factors (Chur, Switzerland) 40 (5-6) (2022)
Jing Lin, Xiaochun Wu
Halofuginone inhibits cell proliferation and AKT/mTORC1 signaling in uterine leiomyoma cells. Growth factors (Chur, Switzerland) 40 (5-6) (2022)
Yan Zhang, Yuanyuan Duan, Chenguang Wu, Wen Peng, Wenyu Chen, Li Wang, Zhaoqun Deng
MiR-200c regulates invasion, proliferation and EMT of anaplastic thyroid cancer cells by targeting parathyroid hormone like hormone. Growth factors (Chur, Switzerland) 40 (5-6) (2022)
Khamhee Wangsa, Krishnakshi Misra, Upasa Gowala, Indira Sarma, Purba Jyoti Saikia, Hirendra Nath Sarma
Embryonic growth retardation and altered expression of IGF-II is reciprocal induced by phytocompounds during early gestation in mice. Growth factors (Chur, Switzerland) 40 (5-6) (2022)